Design of FLAIR: a Phase 2b Study of the 5-Lipoxygenase Activating Protein Inhibitor AZD5718 in Patients With Proteinuric CKD
暂无分享,去创建一个
K. Psachoulia | G. Law | H. Heerspink | E. Lindstedt | H. Ericsson | C. Whatling | K. Connolly | Jane Knöchel | Iain MacPhee